![Pascal Prigent](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pascal Prigent
Chief Executive Officer at
GENFIT
Net worth: 315 345 $ as of 2026-05-30
Profile
Pascal Prigent is currently the Chief Executive Officer at Genfit SA. Previously, he held the position of Vice President & General Manager at GlaxoSmithkline SRL from 2011 to 2014, and Vice President-Marketing at GlaxoSmithKline LLC from 2014 to 2017.
Mr. Prigent obtained an MBA from INSEAD in 1995 and an undergraduate degree from NEOMA Business School in 1989.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
GENFIT SA 0.06% | 2025-03-31 | 30,708 ( 0.06% ) | 315 345 $ | 2026-05-30 |
Pascal Prigent active positions
| Companies | Position | Start |
|---|---|---|
| GENFIT | Chief Executive Officer | 2019-09-15 |
Former positions of Pascal Prigent
| Companies | Position | End |
|---|---|---|
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Sales & Marketing | 2017-10-31 |
GlaxoSmithkline SRL
 GlaxoSmithkline SRL Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithkline SRL is a Romanian biopharmaceutical company that operates in around 70 markets with a focus on preventing and treating diseases through specialty medicines, vaccines, and general medicines. The company’s research and development centers on respiratory, immunology and inflammation, oncology, HIV, and infectious diseases, using technologies such as human genetics, functional genomics, artificial intelligence, and machine learning. GlaxoSmithkline maintains a broad portfolio in infectious diseases, including vaccines, antibiotics, antivirals, and antifungals, and addresses health challenges like antimicrobial resistance and respiratory viruses. The company invests in research and development, maintains a pipeline of medicines and vaccines, and promotes ethical standards, transparency, and data sharing. GlaxoSmithkline collaborates with healthcare professionals, adheres to industry codes for transparency, and supports initiatives related to health, environment, and ethical governance. The company also provides shareholder services and maintains communication with stakeholders through various channels. | Corporate Officer/Principal | 2014-02-28 |
Training of Pascal Prigent
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
85
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
INSEAD
 INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genfit SA
 Genfit SA BiotechnologyHealth Technology Engages in research and development of medicines and diagnostic solutions | Health Technology |
GlaxoSmithkline SRL
GlaxoSmithkline SRL Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithkline SRL is a Romanian biopharmaceutical company that operates in around 70 markets with a focus on preventing and treating diseases through specialty medicines, vaccines, and general medicines. The company’s research and development centers on respiratory, immunology and inflammation, oncology, HIV, and infectious diseases, using technologies such as human genetics, functional genomics, artificial intelligence, and machine learning. GlaxoSmithkline maintains a broad portfolio in infectious diseases, including vaccines, antibiotics, antivirals, and antifungals, and addresses health challenges like antimicrobial resistance and respiratory viruses. The company invests in research and development, maintains a pipeline of medicines and vaccines, and promotes ethical standards, transparency, and data sharing. GlaxoSmithkline collaborates with healthcare professionals, adheres to industry codes for transparency, and supports initiatives related to health, environment, and ethical governance. The company also provides shareholder services and maintains communication with stakeholders through various channels. | Health Technology |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
NEOMA Business School
 NEOMA Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Pascal Prigent
